TBXU ETF

$28.98

Returns Overview

1 Month
-6.04%
3 Months
-19.90%
6 Months
-8.69%
YTD
-5.93%

Risk Metrics (1-Year)

No risk data available for this ETF

Stress Test Scenarios

How would TBXU have held up?
🦠COVID-19 Crash33 days
Market peak to trough during pandemic sell-off
Run Analysis
📈2022 Rate Hikes9 months
Fed aggressive rate hiking cycle bear market
🔒Upgrade to run
📉2018 Q4 Selloff3 months
Trade war fears and Fed tightening
🔒Upgrade to run
🏦SVB / Banking Crisis5 days
Regional banking contagion fears
🔒Upgrade to run

1 Month Performance

-6.04%

3 Months Performance

-19.90%

6 Months Performance

-8.69%

1 Year Performance

-

Benchmark & Peers

Benchmark
NYSE Biotechnology Top 5 Equal Weight Index(BIOEW5)
This ETF (YTD)
-5.93%
Peer Avg (YTD)
-1.20%
vs Peers
-4.73%

TBXU ETF Performance

TBXU performance across multiple time periods: 1-month -6.04%, YTD -5.93%.

TBXU returns trail the peer average of -1.20% YTD. With an expense ratio of 0.97%, investors should weigh costs against performance when evaluating this ETF.

TBXU performance comparison shows side-by-side returns with another fund. TBXU alternatives are available in the ETF Screener.

Performance & Returns

Loading chart...

Performance Returns

PeriodTotal ReturnDate Range
1 Month-6.04%Apr 22, 2026 to May 22, 2026
3 Months-19.90%Feb 23, 2026 to May 22, 2026
6 Months-8.69%Nov 24, 2025 to May 22, 2026

All returns shown are total returns, not annualized